The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
Open accessAbstract
Protegrin-1 (PG-1) is a cysteine-rich, 18-residue beta-sheet peptide isolated from porcine leukocytes with antimicrobial activity against a broad range of microorganisms. The MICs of PG-1 against representative gram-positive and gram-negative bacteria ranged from 0.12 to 2 microg/ml. At these levels, PG-1 was rapidly bactericidal in vitro, reducing the number of viable CFU of either methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa by more than three log units in less than 15 min. Resistance to PG-1 did not develop after 11 subculturings of P. aeruginosa or 18 subcultures of MRSA in Mueller-Hinton broth containing PG-1 at one-half the MIC. Under similar conditions of serial passage, the MICs of norfloxacin and gentamicin against P. aeruginosa increased 10 and 190 times, respectively. Similarly, the MIC of norfloxacin against MRSA increased 85 times. Immunocompetent mice inoculated intraperitoneally (i.p.) with P. aeruginosa or S. aureus exhibited 93 to 100% mortality in the vehicle control group compared with 0 to 27% mortality in animals that received a single i.p. injection of PG-1 (0.5 mg/kg of body weight). Mice inoculated with S. aureus by intravenous (i.v.) injection and dosed 0 to 60 min later with a single i.v. injection of PG-1 (5 mg/kg) had a mortality of 7 to 33%, compared to a mortality of 73 to 93% in the vehicle controls. In leukopenic mice inoculated i.v. with vancomycin-resistant Enterococcus faecium, mortality was 87% in the vehicle control group and 33% in animals that received a single i.v. injection of PG-1 (2.5 mg/kg). Taken together, these data indicate that PG-1 has potential for use as an antimicrobial agent in the treatment of local or systemic infections caused by clinically relevant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Sequence and specificity of two antibacterial proteins involved in insect immunity
Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981) · Nature · doi:10.1038/292246a0 · Cited by 1,427
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Ultrasensitive assays for endogenous antimicrobial polypeptides
Lehrer, R. I., Rosenman, M., Harwig, S. S. S. L., Jackson, R., & Eisenhauer, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90021-7 · Cited by 671
PEPTIDES AS WEAPONS AGAINST MICROORGANISMS IN THE CHEMICAL DEFENSE SYSTEM OF VERTEBRATES
Nicolas, P., & Mor, A. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.001425 · Cited by 564
Kokryakov, V. N., Harwig, S. S. L., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., Korneva, H. A., & Lehrer, R. I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80175-t · Cited by 518
Epithelial Antibiotics Induced at Sites of Inflammation
Schonwetter, B. S., Stolzenberg, E. D., & Zasloff, M. A. (1995) · Science · doi:10.1126/science.7886453 · Cited by 407
Principles and practice of infectious diseases
Brook, M. G. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90352-f · Cited by 389
AGERBERTH, B., LEE, J., BERGMAN, T., CARLQUIST, M., BOMAN, H. G., MUTT, V., & JÖRNVALL, H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16442.x · Cited by 348
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes
Fahrner, R. L., Dieckmann, T., Harwig, S. S. L., Lehrer, R. I., Eisenberg, D., & Feigon, J. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90145-3 · Cited by 265
Sampson, B. A., Misra, R., & Benson, S. A. (1989) · Genetics · doi:10.1093/genetics/122.3.491 · Cited by 263
Cationic Bactericidal Peptides
Hancock, R. E. W., Falla, T., & Brown, M. (1995) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60145-9 · Cited by 262
Ganz, T., & Lehrer, R. I. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00076-f · Cited by 261
Synthesis and Solution Structure of the Antimicrobial Peptide Protegrin‐1
Aumelas, A., Mangoni, M., Roumestand, C., Chiche, L., Despaux, E., Grassy, G., Calas, B., & Chavanieu, A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0575p.x · Cited by 181
Russell, J. P., Diamond, G., Tarver, A. P., Scanlin, T. F., & Bevins, C. L. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1565-1568.1996 · Cited by 170
Prophenin‐1, an exceptionally proline‐rich antimicrobial peptide from porcine leukocytes
Harwig, S. S. L., Kokryakov, V. N., Swiderek, K. M., Gm, A., Zhao, C., & Lehrer, R. I. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00210-z · Cited by 99
Identification of a new member of the protegrin family by cDNA cloning
Zhao, C., Liu, L., & Lehrer, R. I. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00493-5 · Cited by 99
The structure of porcine protegrin genes
Zhao, C., Ganz, T., & Lehrer, R. I. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00633-k · Cited by 87
Joosten, H. M. L. J., & Núñez, M. (1995) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.1995.tb01089.x · Cited by 58
Takemura, H., Kaku, M., KOHNO, S., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2280 · Cited by 50
Gene‐Encoded Antibiotics Made in Bacteria
Sahl, H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514658.ch3 · Cited by 35
Cited by
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Metadata
- Authors
- Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J., & Fiddes, J. C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1997-08
- Volume
- 41
- Issue
- 8
- Pages
- 1738-1742
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2144219110
- Cited by
- 384
- References
- 26
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.